APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ischemia Reperfusion Injury

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Selected research

Industry Growth & Trends

Global Ischemia Reperfusion Injury Industry Growth and Trends Forecast to 2032

21 December 2025114 pages

Choose your research edition.

Industry ResearchIschemia Reperfusion Injury Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Ischemia Reperfusion Injury Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ischemia Reperfusion Injury Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ischemia Reperfusion Injury Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ischemia Reperfusion Injury Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

According to APO Research, the global Ischemia Reperfusion Injury market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Ischemia Reperfusion Injury market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ischemia Reperfusion Injury market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ischemia Reperfusion Injury market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ischemia Reperfusion Injury.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Ischemia Reperfusion Injury market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ischemia Reperfusion Injury Market by Company

Angion Biomedica

Catalyst Biosciences

Ischemix Inc

Opsona Therapeutics

Pharming

TheraSource

Bolder Biotechnology

Corline Biomedical

Mifcortx

Balmes Transplantation

NovelMed Therapeutics

Hope Pharmaceuticals

Omeros Corp

Prothix

SBI Pharmaceuticals

Ischemia Reperfusion Injury Segment by Type

Phase 1

Phase 2

Preclinical

Ischemia Reperfusion Injury Segment by Application

Heart Injury

Kidney Injury

Intestine Injury

Other Injury

Ischemia Reperfusion Injury Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ischemia Reperfusion Injury market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ischemia Reperfusion Injury and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ischemia Reperfusion Injury.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Ischemia Reperfusion Injury companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Ischemia Reperfusion Injury Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Ischemia Reperfusion Injury Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Ischemia Reperfusion Injury Market Share by Region (2021-2026) Table 4. Global Ischemia Reperfusion Injury Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Ischemia Reperfusion Injury Market Share by Region (2027-2032) Table 6. Global Ischemia Reperfusion Injury Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Ischemia Reperfusion Injury Market Size Share by Type (2021-2026) Table 9. Global Ischemia Reperfusion Injury Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Ischemia Reperfusion Injury Market Size Share Forecasted by Type (2027-2032) Table 11. North America Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Ischemia Reperfusion Injury Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Ischemia Reperfusion Injury Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Ischemia Reperfusion Injury Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Ischemia Reperfusion Injury Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Ischemia Reperfusion Injury Market Size Share by Application (2021-2026) Table 24. Global Ischemia Reperfusion Injury Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Ischemia Reperfusion Injury Market Size Share Forecasted by Application (2027-2032) Table 26. North America Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Ischemia Reperfusion Injury Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Ischemia Reperfusion Injury Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Ischemia Reperfusion Injury Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Ischemia Reperfusion Injury Industry Trends Table 37. Ischemia Reperfusion Injury Industry Drivers Table 38. Ischemia Reperfusion Injury Industry Opportunities and Challenges Table 39. Ischemia Reperfusion Injury Industry Restraints Table 40. Global Ischemia Reperfusion Injury Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Ischemia Reperfusion Injury Revenue Market Share by Company (2021-2026) Table 42. Global Ischemia Reperfusion Injury Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Ischemia Reperfusion Injury Key Company Headquarters & Area Served Table 44. Global Ischemia Reperfusion Injury Company, Product Type & Application Table 45. Global Ischemia Reperfusion Injury Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Ischemia Reperfusion Injury by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Angion Biomedica Company Information Table 49. Angion Biomedica Business Overview Table 50. Angion Biomedica Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Angion Biomedica Ischemia Reperfusion Injury Product Portfolio Table 52. Angion Biomedica Recent Development Table 53. Catalyst Biosciences Company Information Table 54. Catalyst Biosciences Business Overview Table 55. Catalyst Biosciences Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Catalyst Biosciences Ischemia Reperfusion Injury Product Portfolio Table 57. Catalyst Biosciences Recent Development Table 58. Ischemix Inc Company Information Table 59. Ischemix Inc Business Overview Table 60. Ischemix Inc Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Ischemix Inc Ischemia Reperfusion Injury Product Portfolio Table 62. Ischemix Inc Recent Development Table 63. Opsona Therapeutics Company Information Table 64. Opsona Therapeutics Business Overview Table 65. Opsona Therapeutics Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Opsona Therapeutics Ischemia Reperfusion Injury Product Portfolio Table 67. Opsona Therapeutics Recent Development Table 68. Pharming Company Information Table 69. Pharming Business Overview Table 70. Pharming Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pharming Ischemia Reperfusion Injury Product Portfolio Table 72. Pharming Recent Development Table 73. TheraSource Company Information Table 74. TheraSource Business Overview Table 75. TheraSource Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. TheraSource Ischemia Reperfusion Injury Product Portfolio Table 77. TheraSource Recent Development Table 78. Bolder Biotechnology Company Information Table 79. Bolder Biotechnology Business Overview Table 80. Bolder Biotechnology Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bolder Biotechnology Ischemia Reperfusion Injury Product Portfolio Table 82. Bolder Biotechnology Recent Development Table 83. Corline Biomedical Company Information Table 84. Corline Biomedical Business Overview Table 85. Corline Biomedical Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Corline Biomedical Ischemia Reperfusion Injury Product Portfolio Table 87. Corline Biomedical Recent Development Table 88. Mifcortx Company Information Table 89. Mifcortx Business Overview Table 90. Mifcortx Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Mifcortx Ischemia Reperfusion Injury Product Portfolio Table 92. Mifcortx Recent Development Table 93. Balmes Transplantation Company Information Table 94. Balmes Transplantation Business Overview Table 95. Balmes Transplantation Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Balmes Transplantation Ischemia Reperfusion Injury Product Portfolio Table 97. Balmes Transplantation Recent Development Table 98. NovelMed Therapeutics Company Information Table 99. NovelMed Therapeutics Business Overview Table 100. NovelMed Therapeutics Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. NovelMed Therapeutics Ischemia Reperfusion Injury Product Portfolio Table 102. NovelMed Therapeutics Recent Development Table 103. Hope Pharmaceuticals Company Information Table 104. Hope Pharmaceuticals Business Overview Table 105. Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Hope Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio Table 107. Hope Pharmaceuticals Recent Development Table 108. Omeros Corp Company Information Table 109. Omeros Corp Business Overview Table 110. Omeros Corp Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Omeros Corp Ischemia Reperfusion Injury Product Portfolio Table 112. Omeros Corp Recent Development Table 113. Prothix Company Information Table 114. Prothix Business Overview Table 115. Prothix Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Prothix Ischemia Reperfusion Injury Product Portfolio Table 117. Prothix Recent Development Table 118. SBI Pharmaceuticals Company Information Table 119. SBI Pharmaceuticals Business Overview Table 120. SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. SBI Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio Table 122. SBI Pharmaceuticals Recent Development Table 123. North America Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Ischemia Reperfusion Injury Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Ischemia Reperfusion Injury Market Share by Country (2021-2026) Table 126. North America Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Ischemia Reperfusion Injury Market Share Forecast by Country (2027-2032) Table 128. Europe Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Ischemia Reperfusion Injury Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Ischemia Reperfusion Injury Market Share by Country (2021-2026) Table 131. Europe Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Ischemia Reperfusion Injury Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Ischemia Reperfusion Injury Market Share by Country (2021-2026) Table 136. Asia-Pacific Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Ischemia Reperfusion Injury Market Share Forecast by Country (2027-2032) Table 138. Latin America Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Ischemia Reperfusion Injury Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Ischemia Reperfusion Injury Market Share by Country (2021-2026) Table 141. Latin America Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Ischemia Reperfusion Injury Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2021-2026) Table 146. Middle East & Africa Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Ischemia Reperfusion Injury Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Ischemia Reperfusion Injury Product Image Figure 3. Global Ischemia Reperfusion Injury Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 5. Global Ischemia Reperfusion Injury Market Share by Region: 2025 VS 2032 Figure 6. Global Ischemia Reperfusion Injury Market Share by Region (2021-2032) Figure 7. North America Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Phase 1 Image Figure 13. Global Phase 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Phase 2 Image Figure 15. Global Phase 2 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Preclinical Image Figure 17. Global Preclinical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Ischemia Reperfusion Injury Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Ischemia Reperfusion Injury Market Share by Type 2025 VS 2032 Figure 20. North America Ischemia Reperfusion Injury Market Size Share by Type (2021-2032) Figure 21. Europe Ischemia Reperfusion Injury Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Ischemia Reperfusion Injury Market Size Share by Type (2021-2032) Figure 23. Latin America Ischemia Reperfusion Injury Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Ischemia Reperfusion Injury Market Size Share by Type (2021-2032) Figure 25. Heart Injury Image Figure 26. Global Heart Injury Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Kidney Injury Image Figure 28. Global Kidney Injury Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Intestine Injury Image Figure 30. Global Intestine Injury Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Injury Image Figure 32. Global Other Injury Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Ischemia Reperfusion Injury Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Ischemia Reperfusion Injury Market Share by Application 2025 VS 2032 Figure 35. North America Ischemia Reperfusion Injury Market Size Share by Application (2021-2032) Figure 36. Europe Ischemia Reperfusion Injury Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Ischemia Reperfusion Injury Market Size Share by Application (2021-2032) Figure 38. Latin America Ischemia Reperfusion Injury Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Ischemia Reperfusion Injury Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Ischemia Reperfusion Injury Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Ischemia Reperfusion Injury Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Ischemia Reperfusion Injury Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 45. Europe Ischemia Reperfusion Injury Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Ischemia Reperfusion Injury Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 48. Asia-Pacific Ischemia Reperfusion Injury Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Ischemia Reperfusion Injury Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 51. Latin America Ischemia Reperfusion Injury Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Ischemia Reperfusion Injury Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 54. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Phase 1
  • Phase 2
  • Preclinical
Applications
  • Heart Injury
  • Kidney Injury
  • Intestine Injury
  • Other Injury
Companies covered
  • Angion Biomedica
  • Catalyst Biosciences
  • Ischemix Inc
  • Opsona Therapeutics
  • Pharming
  • TheraSource
  • Bolder Biotechnology
  • Corline Biomedical
  • Mifcortx
  • Balmes Transplantation
  • NovelMed Therapeutics
  • Hope Pharmaceuticals
  • Omeros Corp
  • Prothix
  • SBI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Ischemia Reperfusion Injury Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Ischemia Reperfusion Injury Market Size by Region (2021-2032)
  5. 1.4.1 Global Ischemia Reperfusion Injury Market Size by Region (2021-2026)
  6. 1.4.2 Global Ischemia Reperfusion Injury Market Size by Region (2027-2032)
  7. 1.5 Key Regions Ischemia Reperfusion Injury Market Size (2021-2032)
  8. 1.5.1 North America Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate (2021-2032)
2 Ischemia Reperfusion Injury Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Phase 1
  3. 2.1.2 Phase 2
  4. 2.1.3 Preclinical
  5. 2.2 Global Ischemia Reperfusion Injury Market Size by Type
  6. 2.2.1 Global Ischemia Reperfusion Injury Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Ischemia Reperfusion Injury Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Ischemia Reperfusion Injury Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Ischemia Reperfusion Injury Market Size by Regions
  10. 2.3.1 North America Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Type (2021-2026)
3 Ischemia Reperfusion Injury Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Heart Injury
  3. 3.1.2 Kidney Injury
  4. 3.1.3 Intestine Injury
  5. 3.1.4 Other Injury
  6. 3.2 Global Ischemia Reperfusion Injury Market Size by Application
  7. 3.2.1 Global Ischemia Reperfusion Injury Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Ischemia Reperfusion Injury Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Ischemia Reperfusion Injury Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Ischemia Reperfusion Injury Market Size by Regions
  11. 3.3.1 North America Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Ischemia Reperfusion Injury Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Ischemia Reperfusion Injury Industry Trends
  2. 4.2 Ischemia Reperfusion Injury Industry Drivers
  3. 4.3 Ischemia Reperfusion Injury Industry Opportunities and Challenges
  4. 4.4 Ischemia Reperfusion Injury Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Ischemia Reperfusion Injury Revenue (2021-2026)
  2. 5.2 Global Ischemia Reperfusion Injury Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Ischemia Reperfusion Injury Key Company Headquarters & Area Served
  4. 5.4 Global Ischemia Reperfusion Injury Company, Product Type & Application
  5. 5.5 Global Ischemia Reperfusion Injury Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Ischemia Reperfusion Injury Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Ischemia Reperfusion Injury Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Ischemia Reperfusion Injury Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Angion Biomedica
  2. 6.1.1 Angion Biomedica Company Information
  3. 6.1.2 Angion Biomedica Business Overview
  4. 6.1.3 Angion Biomedica Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Angion Biomedica Ischemia Reperfusion Injury Product Portfolio
  6. 6.1.5 Angion Biomedica Recent Developments
  7. 6.2 Catalyst Biosciences
  8. 6.2.1 Catalyst Biosciences Company Information
  9. 6.2.2 Catalyst Biosciences Business Overview
  10. 6.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Catalyst Biosciences Ischemia Reperfusion Injury Product Portfolio
  12. 6.2.5 Catalyst Biosciences Recent Developments
  13. 6.3 Ischemix Inc
  14. 6.3.1 Ischemix Inc Company Information
  15. 6.3.2 Ischemix Inc Business Overview
  16. 6.3.3 Ischemix Inc Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Ischemix Inc Ischemia Reperfusion Injury Product Portfolio
  18. 6.3.5 Ischemix Inc Recent Developments
  19. 6.4 Opsona Therapeutics
  20. 6.4.1 Opsona Therapeutics Company Information
  21. 6.4.2 Opsona Therapeutics Business Overview
  22. 6.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Opsona Therapeutics Ischemia Reperfusion Injury Product Portfolio
  24. 6.4.5 Opsona Therapeutics Recent Developments
  25. 6.5 Pharming
  26. 6.5.1 Pharming Company Information
  27. 6.5.2 Pharming Business Overview
  28. 6.5.3 Pharming Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pharming Ischemia Reperfusion Injury Product Portfolio
  30. 6.5.5 Pharming Recent Developments
  31. 6.6 TheraSource
  32. 6.6.1 TheraSource Company Information
  33. 6.6.2 TheraSource Business Overview
  34. 6.6.3 TheraSource Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 TheraSource Ischemia Reperfusion Injury Product Portfolio
  36. 6.6.5 TheraSource Recent Developments
  37. 6.7 Bolder Biotechnology
  38. 6.7.1 Bolder Biotechnology Company Information
  39. 6.7.2 Bolder Biotechnology Business Overview
  40. 6.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bolder Biotechnology Ischemia Reperfusion Injury Product Portfolio
  42. 6.7.5 Bolder Biotechnology Recent Developments
  43. 6.8 Corline Biomedical
  44. 6.8.1 Corline Biomedical Company Information
  45. 6.8.2 Corline Biomedical Business Overview
  46. 6.8.3 Corline Biomedical Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Corline Biomedical Ischemia Reperfusion Injury Product Portfolio
  48. 6.8.5 Corline Biomedical Recent Developments
  49. 6.9 Mifcortx
  50. 6.9.1 Mifcortx Company Information
  51. 6.9.2 Mifcortx Business Overview
  52. 6.9.3 Mifcortx Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Mifcortx Ischemia Reperfusion Injury Product Portfolio
  54. 6.9.5 Mifcortx Recent Developments
  55. 6.10 Balmes Transplantation
  56. 6.10.1 Balmes Transplantation Company Information
  57. 6.10.2 Balmes Transplantation Business Overview
  58. 6.10.3 Balmes Transplantation Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Balmes Transplantation Ischemia Reperfusion Injury Product Portfolio
  60. 6.10.5 Balmes Transplantation Recent Developments
  61. 6.11 NovelMed Therapeutics
  62. 6.11.1 NovelMed Therapeutics Company Information
  63. 6.11.2 NovelMed Therapeutics Business Overview
  64. 6.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 NovelMed Therapeutics Ischemia Reperfusion Injury Product Portfolio
  66. 6.11.5 NovelMed Therapeutics Recent Developments
  67. 6.12 Hope Pharmaceuticals
  68. 6.12.1 Hope Pharmaceuticals Company Information
  69. 6.12.2 Hope Pharmaceuticals Business Overview
  70. 6.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
  72. 6.12.5 Hope Pharmaceuticals Recent Developments
  73. 6.13 Omeros Corp
  74. 6.13.1 Omeros Corp Company Information
  75. 6.13.2 Omeros Corp Business Overview
  76. 6.13.3 Omeros Corp Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Omeros Corp Ischemia Reperfusion Injury Product Portfolio
  78. 6.13.5 Omeros Corp Recent Developments
  79. 6.14 Prothix
  80. 6.14.1 Prothix Company Information
  81. 6.14.2 Prothix Business Overview
  82. 6.14.3 Prothix Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Prothix Ischemia Reperfusion Injury Product Portfolio
  84. 6.14.5 Prothix Recent Developments
  85. 6.15 SBI Pharmaceuticals
  86. 6.15.1 SBI Pharmaceuticals Company Information
  87. 6.15.2 SBI Pharmaceuticals Business Overview
  88. 6.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
  90. 6.15.5 SBI Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  3. 7.3 North America Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  3. 8.3 Europe Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  3. 10.3 South America Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Ischemia Reperfusion Injury Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst